已发表的部分文献: 标题:All-trans retinoic acid and sodium butyrate enhance natriuretic peptide receptor a gene transcription: role of histone modification.作者:Kumar P, Periyasamy R, Das S, Neerukonda S, Mani I, Pandey KN;杂志名称:Mol Pharmacol 标题:Elevated expression of histone demethylase PHF8 associates with adverse prognosis in patients of laryngeal and hypopharyngeal squamous cell carcinoma.作者:Zhu G, Liu L, She L, Tan H, Wei M, Chen C, Su Z, Huang D, Tian Y, Qiu Y, Liu Y, Zhang X;杂志名称:Epigenomics 标题:Global quantification of heterochromatin-associated histone methylations in cell lines with differential sensitivity to ionizing radiation.作者:Cetinkaya M, Özgür E, Dalay N, Gezer U;杂志名称:Acta Biochim Pol 标题:Force-induced gene up-regulation does not follow the weak power law but depends on H3K9 demethylation.作者:Sun J, Chen J, Mohagheghian E, Wang N;杂志名称:Sci Adv 标题:Perinatal inflammation alters histone 3 and histone 4 methylation patterns: Effects of MiR-29b supplementation.作者:Sugar SS, Heyob KM, Cheng X, Lee RJ, Rogers LK;杂志名称:Redox Biol Epigentek 公司是全球领先的表观遗传学相关研究的技术创新者和产品开发供应商。开发了超过700多个专利产品,为表观遗传学方面的研究和新药研发提供全面系统的解决方案,涵盖样品制备、DNA/RNA甲基化(5-mc, 5-hmc, 5-fc, m6A)/DNMT分析、ChIP、组蛋白甲基化/乙酰化/去乙酰化/磷酸化/SUMO-等领域,提供小分子抑制剂、蛋白质、抗体、以及分析试剂盒产品。